Related Experiment Video
Updated: Jun 27, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Advances in hormone replacement therapy: making the menopause manageable
1Palacios Institute of Women's Health, Calle Antonio Acuña, 9, 28009, Madrid, España. ipalacios@institutopalacios.com
Hormone Replacement Therapy (HRT) risk/benefit perception is shifting. Younger women may benefit from HRT for coronary disease prevention, while older women face increased risks; individualized treatment is key.
Area of Science:
- Reproductive Endocrinology
- Cardiovascular Health
- Gerontology
Background:
- Large randomized controlled trials (RCTs) have altered the understanding of Hormone Replacement Therapy (HRT) risks and benefits.
- Recent literature suggests a revised approach to HRT management is warranted.
Purpose of the Study:
- To review current literature on HRT, focusing on age at initiation, duration, and specific health outcomes.
- To evaluate the efficacy and safety of varying HRT doses and components.
Main Methods:
- Literature review of recent studies and randomized controlled trials.
- Analysis of HRT effects based on age, menopausal status, and treatment duration.
Main Results:
- HRT may decrease coronary disease risk in younger, peri-menopausal women but increase risk in older women.
- Low-dose HRT is effective for vasomotor symptoms, genital atrophy, and bone loss prevention with fewer side effects.
- Testosterone therapy shows efficacy in improving sexual function in postmenopausal women.
Conclusions:
- HRT management requires individualization based on age, menopausal status, symptom severity, and treatment goals.
- Further research is needed on HRT's long-term effects on fractures, cardiovascular, and breast health.
- Newer progestins and testosterone formulations offer distinct therapeutic possibilities.
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation
Hormonal Regulation
Mitral Valve Prolapse III: Nursing Management

